The Effect of DNS Therapy on Asymmetry in Children After Surgery of Congenital Heart Disease
Condition(s) studied
Investigational drug(s) / intervention(s)
Dynamic neuromuscular stabilisation: The nervous system establishes programs that control human posture, movement and gait. This 'motor control' is largely established during the first critical years of life. Therefore, the "Prague School" emphasizes neurodevelopmental aspects of motor control in order to assess and restore dysfunction of the locomotor system and associated syndromes.
Study summary
This thesis will examine the consequences of congenital heart disease (CHD) surgery in children. The main goal of this work is to point out the possible development of late consequences after cardiac surgery in childhood (e.g. asymmetry, scoliosis, hypomobility of the spine) and to assess the effect of DNS therapy on the resolution of the consequences. For patients, after an intensive three-week rehabilitation intervention, an improvement in the monitored initial parameters is expected, which would lead to an improvement in the quality of life.
Eligibility
Primary outcome measure(s)
- Mobility of the spine - Stibor distance — From enrollment to the end of treatment at 3 weeks
The Stibor distance shows the development of the thoracic and lumbar spine. The starting point is the spine of the L5 vertebra, the second point is the spine of the C7 vertebra. The distance between them is measured and its change during relaxed forward bending are observed. A healthy spine should lengthen by 7-10 cm. - Mobility of the spine - Otto's inclination distance — From enrollment to the end of treatment at 3 weeks
Otto's inclination distance measures the mobility of the thoracic spine during forward bending. The starting point is the spine of the C7 vertebra, from which we measure 30 cm caudally. The distance of the points shown increases by at least 3.5 cm with forward tilt.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Motol University Hospital | Prague | Czechia |
More Charles University, Czech Republic trials in Czechia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06776822 on ClinicalTrials.gov ↗ ← All trials in Czechia